Invention Grant
- Patent Title: Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody
-
Application No.: US16580509Application Date: 2019-09-24
-
Publication No.: US10961307B2Publication Date: 2021-03-30
- Inventor: Jewel Johanns , Katherine Li , Colleen Marano , Richard Strauss , Hongyan Zhang , Christopher O'Brien , Omoniyi Adedokun , Kimberly Shields-Tuttle
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agent Eric Dichter
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C07K16/24 ; A61K9/08 ; A61K47/22 ; A61K47/26 ; A61K47/18 ; A61P1/04 ; A61K9/00
Abstract:
Described are methods and compositions for clinical proven safe and effective treatment of ulcerative colitis, particularly moderately to severely active ulcerative colitis in patients who have had an inadequate response to or are intolerant of a conventional or existing therapy by intravenous and/or subcutaneous administration of an anti-IL-12/IL-23p40 antibody.
Public/Granted literature
- US20200095315A1 Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody Public/Granted day:2020-03-26
Information query
